Suchen und Finden

Titel

Autor/Verlag

Inhaltsverzeichnis

Nur eBooks für mein Endgerät anzeigen:

 

Newsletter

Osteoporosis - Diagnosis, Prevention, Therapy

Osteoporosis - Diagnosis, Prevention, Therapy

von: Reiner Bartl, Bertha Frisch

Springer-Verlag, 2009

ISBN: 9783540795278, 313 Seiten

2. Auflage

Format: PDF, OL

Mac OSX,Windows PC Apple iPad, Android Tablet PC's Online-Lesen für: Linux,Mac OSX,Windows PC

Preis: 64,15 EUR

Mehr zum Inhalt

Osteoporosis - Diagnosis, Prevention, Therapy


 

Preface

5

Contents

7

Epidemiology of Osteoporosis

11

1.1 Osteoporosis: A Silent Thief!

11

1.2 Osteoporosis: The Global Scope of the Problem

12

Biology of Bone

17

2.1 Bone: An Architectural Masterpiece

17

2.2 Bone: A Permanent Building and Rebuilding Site

20

2.3 Remodelling Units

25

2.4 Some Biological Perspectives on the Mechanisms Involved in the Control and Regulation of Bone Remodelling

27

2.5 Minimodelling

28

2.6 Stimuli, Triggers and Mechanisms of Activation of Bone Remodelling

29

2.7 Control of Bone Remodelling: A Network of Complex Mechanisms

30

2.8 Osteoimmunology: A Representative of Systems Biology

33

2.9 The RANK/RANKL/Osteoprotegerin System

33

2.10 Leptin: Role of the Central Nervous System in Regulation of Bone

35

2.11 Growth of the Embryo in the Uterus

36

2.12 Peak Bone Mass: An Investment for a Healthier Life

37

Pathogenesis of Osteoporosis

39

3.1 Factors in the Development of Osteoporosis

39

3.2 Def inition of Osteoporosis

40

3.3 Osteoporosis – Which Bones are Vulnerable?

41

3.4 Osteoporosis – Also a Question of Quality!

42

3.5 Definition of “Fracture&rdquo

44

3.6 Vertebral ( Spinal) Fractures

44

3.7 Hip Fractures

46

3.8 Wrist Fractures

47

3.9 Other Fractures

47

Subgroups of Osteoporosis

48

4.1 According to Spread

48

4.2 According to Age and Sex

49

4.3 According to Extent

51

4.4 According to Histology

52

Risk Factors for Fractures

54

5.1 Risk Factors Which Cannot (yet) be Influenced

55

5.2 Risk Factors Which Can be Influenced

57

Clinical Evaluation of Osteoporosis

64

6.1 Indicative Symptoms

64

6.2 Osteoporosis and Teeth, Skin and Hair – What are the Connections?

66

6.3 Role of Conventional X- Rays in Osteoporosis

66

6.4 Other Useful Imaging Techniques

69

Bone Density in Osteoporosis

72

7.1 Why Measure Bone Mineral Density?

72

7.2 Which Instruments to Use?

72

7.3 Which Bones to Measure?

79

7.4 Who is Due or Overdue for a BMD Test?

79

7.5 Bone Densitometry in Children – Now Readily Available!

81

7.6 BMD Measurement – Not a Scary Procedure, Nothing to be Afraid of!

82

Laboratory Evaluation of Osteoporosis

83

8.1 Recommended Tests

83

8.2 Significance of Markers of Bone Turnover

83

8.3 Recommendations for Practical Use of Bone Markers

87

8.4 Potential of Bone Biopsy in Clinical Practice

87

8.5 When is a Bone Biopsy Indicated?

88

8.6 Up-to- Date Methods

89

Prevention of Osteoporosis

91

9.1 Step 1: First of all a Calcium- Rich Diet!

91

9.2 Step 2: Ensure an Adequate Supply of Vitamins!

93

9.3 Step 3: Protect the Spine in Everyday Life!

94

9.4 Step 4: Regular Physical Activity – for the Preservation of Strong Bones!

95

9.5 Step 5: No Smoking, Please!

98

9.6 Step 6: Reduce Nutritional “ Bone Robbers”!

98

9.7 Step 7: Strive for an Ideal Body Weight!

99

9.8 Step 8: Identify Drugs that Cause Osteoporosis and Take Appropriate Steps to Counteract Them When Possible and Necessary!

100

9.9 Step 9: Recognize Diseases Which Damage Bones!

100

9.10 Step 10: Management of Patients Who Have Already Sustained a Fracture

101

Physical Activity and Exercise Programs

102

10.1 Strong Muscles Make and Maintain Strong Bones!

102

10.2 The Muscle– Bone Unit and Sarcopenia

103

10.3 Exercise Programs – Preventive and Restorative

104

10.4 Implementation of a Training Program

104

Treatment Strategies in Osteoporosis

105

11.1 Evidence- Based Strategies for the Therapy of Osteoporosis

105

11.2 Comprehensive Approach to the Therapy of Osteoporosis

109

11.3 Indication for Treatment – Combining BMD with Clinical Factors

110

Management of Pain in Osteoporosis

112

12.1 Start with the Patient, not the Disease!

112

12.2 Acute Phase

112

12.3 Chronic Phase – Short Term

113

12.4 Chronic Phase – Long Term

114

12.5 Electric Potentials in Bone

114

Calcium and Vitamin D

115

13.1 Calcium: A Lifelong Companion

115

13.2 The Concept of Vitamin D in the 21st Century

117

13.3 Vitamin D: Don’t Rely on Sunshine, Take Supplements

118

13.4 Rickets

119

13.5 Other Vitamins Involved in Skeletal Health

121

Hormones for Replacement Therapy

122

14.1 Hormone Replacement Therapy for Women – Now Recommended for Symptoms Only!

122

14.2 Which Oestrogens and Progestins, and How to Take Them?

123

14.3 Which Women to Treat?

124

14.4 How Long to Treat?

124

14.5 How to Monitor HRT?

124

14.6 What are the Risks and Adverse Events of HRT?

125

14.7 What are the Main Contraindications?

125

14.8 Natural Oestrogens – How Effective are They?

125

14.9 Dehydroepiandrosterone (DHEA) – Is it Useful for the Prevention of Bone Loss?

127

14.10 Testosterone – Good for Bones and Well- Being in Men!

127

14.11 Anabolic Steroids – Strong Muscles for Healthy Bones!

127

Bisphosphonates

129

15.1 A Brief Survey of Bisphosphonates

130

15.2 Pharmacokinetics

133

15.3 Toxicity and Contraindications

134

15.4 Osteomyelitis/Osteonecrosis of the Jaw ( ONJ)

135

15.5 Contraindications

137

15.6 Oral Bisphosphonates Currently Used in Osteoporosis

137

15.7 Alendronate

137

15.8 Risedronate

138

15.9 Etidronate

139

15.10 Ibandronate

139

15.11 Intravenous Bisphosphonates for the Treatment of Osteoporosis

140

15.12 Ibandronate

140

15.13 Zoledronate

140

15.14 Clodronate and Pamidronate

141

15.15 Recommendations for Intravenous Therapy

141

15.16 Duration of Therapy with Bisphosphonates and Long- Term Studies

141

15.17 A Summary of Results Achieved to Date

142

15.18 Meta-analyses of Antiresorptive Substances

144

Selective Oestrogen- Receptor Modulators

146

16.1 A Brief Overview of SERMs – New Selective Antiresorptive Agents

146

16.2 Raloxifene – Utilization of Physiological Eff ects on Bone

146

Peptides of the Parathyroid Hormone Family

149

17.1 Osteoanabolic Action of PTH – Paradoxical Eff ects Depend on Type of Administration

149

Strontium Ranelate

152

Calcitonin and Fluoride

154

Combination and Sequential Therapies

156

Future Directions

158

22.1 Adherence to Treatment

160

22.2 Monitoring Treatment

160

Adherence and Monitoring of Osteoporosis Therapy

160

22.3 Monitoring Antiresorptive Therapy

162

22.4 Monitoring Osteo-anabolic Therapy

163

Osteoporotic Fractures

164

23.1 Fragility Fractures

164

23.2 Fractures and the Healing Process

165

23.3 Effects of Drugs and Lifestyle on Fracture Healing

166

23.4 Risk Factors for Osteoporotic Fractures

167

23.5 Management of Osteoporotic Fractures

170

23.6 Prevention of Further Fragility Fractures with Specific Drugs

170

23.7 Fracture Sites and Their Clinical Significance

170

Pregnancy and Lactation

178

Osteoporosis in Men

181

25.1 Clinical Evaluation of Osteoporosis in Men

181

25.2 Special Features in Men

184

25.3 Prevention and Treatment in Men

184

25.4 Therapy of Osteoporosis in Men

185

Osteoporosis in Children

187

26.1 First Clarification – Hereditary or Acquired?

187

26.2 Idiopathic Juvenile Osteoporosis, Idiopathic Juvenile Arthritis, and Other Conditions

192

26.3 Osteogenesis Imperfecta Must Not Be Overlooked!

193

26.4 Turner Syndrome and Charge Syndrome

195

26.5 X- Linked Hypophosphatemic Rickets

195

26.6 Gaucher’s Disease

195

Immobilization Osteoporosis

197

27.1 Examples of Bone Loss

197

27.2 Space Travel and the Force of Gravity

198

27.3 Therapy of Immobilization Osteoporosis

198

Osteoporosis in Medical Disciplines

200

28.1 Assessment of Secondary Osteoporoses

200

28.2 Cardiology

200

28.3 Dermatology

202

28.4 Endocrinology

202

28.5 Gastroenterology

204

28.6 Genetics

204

28.7 Haematology and Storage Disorders

205

28.8 Infectious Disorders

207

28.9 Nephrology

208

28.10 Neurology and Psychiatry

209

28.11 Oncology

209

28.12 Pulmonology

210

28.13 Rheumatology and Immunology

210

Osteoporosis and Drugs

212

29.1 Corticosteroid- Induced Osteoporosis

212

29.2 Transplantation Osteoporosis

214

29.3 Tumour Therapy- Induced Osteoporosis

216

29.4 Drug- Induced Osteoporomalacia

219

29.5 Antiepileptic Drug- Related Osteopathy, a Pressing Need for Better Understanding

219

AIDS Osteopathy

221

30.1 Manifestations of AIDS Osteopathy

222

30.2 Diagnosis

223

30.3 Treatment Strategies

224

Renal Osteopathy

225

31.1 Definition

225

31.2 Pathophysiology

225

31.3 Symptoms

226

31.4 Biochemical Investigation

226

31.5 Radiological Investigation

226

31.6 Treatment Strategies

227

Localized Osteopathies

229

32.1 Complex Regional Pain Syndrome ( CRPS)

229

32.2 Transient Osteoporosis and the Bone Marrow Oedema Syndrome ( BMOS)

231

32.3 Vanishing Bone Disease ( Gorham- Stout Syndrome)

235

32.4 Fibrous Dysplasia

237

32.5 Paget’s Disease of Bone

238

Periprosthetic Osteoporosis and Aseptic Loosening of Prostheses

242

33.1 Pathogenesis

242

33.2 Diagnosis

244

33.3 Treatment Strategies

244

33.4 Bisphosphonates

244

Oral Bone Loss, Periodontitis and Osteoporosis

246

34.1 Oral Bone Loss and Systemic Osteoporosis

246

34.2 Pathogenesis of Periodontitis

246

34.3 Clinical Findings

246

34.4 Treatment Strategies

247

34.5 Bisphosphonates

247

Disorders of Bone Due to Tumours

248

35.1 Links Between Osteoporosis and Cancer

248

35.2 Tumour-Induced Hypercalcaemia (TIH)

248

35.3 Tumour- Induced Bone Pain (TIBP)

249

35.4 Skeletal Manifestations in Multiple Myeloma ( MM)

251

35.5 Skeletal Metastases – The Fundamental Problem in Clinical Oncology

252

35.6 Skeletal Metastases of Breast and Prostate Cancer

254

The Metabolic Syndrome – A Major Cause of Osteoporosis in the World Today

259

Bibliography

264

Introduction

264

Books on Osteoporosis

264

Selected Articles in Journals

266

Chapter 1 Epidemiology of Osteoporosis

266

Chapter 2 Biology of Bone

268

Chapter 3 Pathogenesis of Osteoporosis

272

Chapter 4 Subgroups of Osteoporosis

273

Chapter 5 Risk Factors for Fractures

273

Chapter 6 Clinical Evaluation of Osteoporosis

275

Chapter 7 Bone Density in Osteoporosis

276

Chapter 8 Laboratory Evaluation of Osteoporosis

277

Chapter 9 Prevention of Osteoporosis

278

Chapter 10 Physical Activity and Exercise Programs

278

Chapter 11 Treatment Strategies in Osteoporosis

280

Chapter 12 Management of Pain in Osteoporosis

280

Chapter 13 Calcium and Vitamin D

281

Chapter 14 Hormones for Replacement Therapy

283

Chapter 15 Bisphosphonates

283

Chapter 16 Selective Oestrogen- Receptor Modulators

287

Chapter 17 Peptides of the Parathyroid Hormone Family

287

Chapter 18 Strontium Ranelate

288

Chapter 19 Calcitonin and Fluoride

288

Chapter 20 Combination and Sequential Therapies

289

Chapter 21 Future Directions

289

Chapter 22 Adherence and Monitoring of Osteoporosis Therapy

289

Chapter 23 Osteoporotic Fractures

290

Chapter 24 Pregnancy and Lactation

292

Chapter 25 Osteoporosis in Men

292

Chapter 26 Osteoporosis in Children

293

Chapter 27 Immobilization Osteoporosis

295

Chapter 28 Osteoporosis in Medical Disciplines

295

Chapter 29 Osteoporosis and Drugs

297

Chapter 30 AIDS Osteopathy

298

Chapter 31 Renal Osteopathy

299

Chapter 32 Localized Osteopathies

299

Chapter 33 Periprosthetic Osteoporosis and Aseptic Loosening of Prostheses

300

Chapter 34 Oral Bone Loss, Periodontitis and Osteoporosis

301

Chapter 35 Disorders of Bone due to Tumours

302

Chapter 36 The Metabolic Syndrome – A Major Cause of Osteoporosis in the World Today

302

Subject Index

305